WallStSmart

Re Max Holding (RMAX)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 4408% more annual revenue ($12.76B vs $283.12M). WELL leads profitability with a 12.1% profit margin vs -3.0%. WELL appears more attractively valued with a PEG of 3.62. WELL earns a higher WallStSmart Score of 57/100 (C).

RMAX

Hold

40

out of 100

Grade: D

Growth: 2.0Profit: 4.5Value: 4.0Quality: 4.5
Piotroski: 4/9Altman Z: 0.69

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for RMAX.

WELLSignificantly Overvalued (-87.0%)

Margin of Safety

-87.0%

Fair Value

$125.97

Current Price

$235.62

$109.65 premium

UndervaluedFair: $125.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RMAX1 strengths · Avg: 10.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

RMAX4 concerns · Avg: 2.5/10
Market CapQuality
$681.16M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.023/10

Elevated debt levels

PEG RatioValuation
4.072/10

Expensive relative to growth rate

Return on EquityProfitability
-1.9%2/10

ROE of -1.9% — below average capital efficiency

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : RMAX

The strongest argument for RMAX centers on Price/Book.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : RMAX

The primary concerns for RMAX are Market Cap, Debt/Equity, PEG Ratio.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Key Dynamics to Monitor

RMAX profiles as a turnaround stock while WELL is a growth play — different risk/reward profiles.

RMAX carries more volatility with a beta of 1.84 — expect wider price swings.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 40/100) and 39.1% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Re Max Holding

REAL ESTATE · REAL ESTATE SERVICES · USA

RE / MAX Holdings, Inc. is a franchisor of real estate and mortgage brokerage services in the United States, Canada, and internationally. The company is headquartered in Denver, Colorado.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?